Soluble beta-amyloid peptides mediate vasoactivity via activation of a pro-inflammatory pathway. (Q54132112)

25 May 2018

title

Soluble beta-amyloid peptides mediate vasoactivity via activation of a pro-inflammatory pathway. (English)

1 reference

25 May 2018

0 references

6

1 reference

25 May 2018

author name string

D Paris

1

1 reference

25 May 2018

T Town

2

1 reference

25 May 2018

T Mori

3

1 reference

25 May 2018

T A Parker

4

1 reference

25 May 2018

J Humphrey

5

1 reference

25 May 2018

publication date

1 March 2000

1 reference

25 May 2018

published in

Neurobiology of Aging

1 reference

25 May 2018

volume

21

1 reference

25 May 2018

issue

2

1 reference

25 May 2018

page(s)

183-197

1 reference

25 May 2018

5-lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Inhibition of macrophage Ca(2+)-independent phospholipase A2 by bromoenol lactone and trifluoromethyl ketones.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Serum phospholipase A2 activity in chronic pancreatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Selective inhibition of prostaglandin endoperoxide synthase-1 (cyclooxygenase-1) by valerylsalicylic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Direct Inhibition of Cyclooxygenase-1 and -2 by the Kinase Inhibitors SB 203580 and PD 98059

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Expression of cyclooxygenase-2 in rat vascular smooth muscle cells is unrelated to nuclear factor-kappaB activation

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

The cellular pathology associated with Alzheimer beta-amyloid deposits in non-demented aged individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Characteristics of the in vitro vasoactivity of beta-amyloid peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

The growing phospholipase A2 superfamily of signal transduction enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Positron emission tomography in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

A synthetic inhibitor of the mitogen-activated protein kinase cascade

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Membrane phospholipid alterations in Alzheimer's disease: deficiency of ethanolamine plasmalogens

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Phospholipase A2 inhibitors regulate the proliferation of normal uterine cells

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Translocation of the 85-kDa phospholipase A2 from cytosol to the nuclear envelope in rat basophilic leukemia cells stimulated with calcium ionophore or IgE/antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Inhibition of protein kinase C by melittin: antagonism of binding interactions between melittin and the catalytic domain by active-site binding of MgATP.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Induction of cyclooxygenase-2 by the activated MEKK1 --> SEK1/MKK4 --> p38 mitogen-activated protein kinase pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Bacterial expression and characterization of human pancreatic phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Resistance to endotoxic shock in phospholipase A2 receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

p38 kinase is activated in the Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Secretory phospholipase A2 activates the cascade of mitogen-activated protein kinases and cytosolic phospholipase A2 in the human astrocytoma cell line 1321N1.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Role of protein kinase C alpha in endothelin-1 stimulation of cytosolic phospholipase A2 and arachidonic acid release in cultured cat iris sphincter smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Cross-talk between secretory phospholipase A2 and cytosolic phospholipase A2 in rat renal mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

The toxicity in vitro of beta-amyloid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

The formation of prostaglandins in the postmortem cerebral cortex of Alzheimer-type dementia patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Lipid peroxidation and free radical scavengers in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Cerebral perfusion imaging in Alzheimer's disease. Use of single photon emission computed tomography and iofetamine hydrochloride I 123

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Migration of vascular smooth muscle cells by phospholipase A2 via specific binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Inhibitors of cytochrome P-450 attenuate the myogenic response of dog renal arcuate arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Activation of GTP formation and high-affinity GTP hydrolysis by mastoparan in various cell membranes. G-protein activation via nucleoside diphosphate kinase, a possible general mechanism of mastoparan action

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

High levels of circulating Abeta42 are sequestered by plasma proteins in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Activation of phospholipase A2 by amyloid beta-peptides in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Epoxyeicosatrienoic acids activate K+ channels in coronary smooth muscle through a guanine nucleotide binding protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

cPLA2 is phosphorylated and activated by MAP kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Selective inhibition of group II phospholipase A2 by quercetin

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

The role of selective cyclooxygenase isoforms in human intestinal smooth muscle cell stimulated prostanoid formation and proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Inflammation of the brain in Alzheimer's disease: implications for therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

The functions of five distinct mammalian phospholipase A2S in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2S are functionally redundant and act in concert with cytosolic phospholipase A2

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

beta-Amyloid peptide produced in vitro is degraded by proteinases released by cultured cells

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Effect of pancreatic type phospholipase A2 on isolated porcine cerebral arteries via its specific binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Evidence for a membrane defect in Alzheimer disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Ligand-dependent G protein coupling function of amyloid transmembrane precursor

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

A novel inhibitory effect on prostacyclin synthesis of coupling factor 6 extracted from the heart of spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Effect of interleukin-1 beta, tumour necrosis factor-alpha and interferon-gamma on the induction of cyclo-oxygenase-2 in cultured human airway smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Role of peroxynitrite in the vasoactive and cytotoxic effects of Alzheimer's beta-amyloid1-40 peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Isoform-specific vasoconstriction induced by apolipoprotein E and modulation of this effect by Alzheimer's beta-amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Inhibition of Alzheimer's beta-amyloid induced vasoactivity and proinflammatory response in microglia by a cGMP-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Amyloid beta-protein and the genetics of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Lipid mediator networks in cell signaling: update and impact of cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Role of the beta-amyloid protein in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Risk of Alzheimer's disease and duration of NSAID use.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Soluble Alzheimers beta-amyloid constricts the cerebral vasculature in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Mechanisms of the priming effect of lipopolysaccharides on the biosynthesis of leukotriene B4 in chemotactic peptide-stimulated human neutrophils.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

beta-Amyloid-mediated vasoactivity and vascular endothelial damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

A reassessment of the low molecular weight phospholipase A2 gene family in mammals

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Complement C1 inhibitor is produced by brain tissue and is cleaved in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Migration of perivascular cells into the neuropil and their involvement in beta-amyloid plaque formation

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

Angiotensin II type 2 receptor stimulation of neuronal delayed-rectifier potassium current involves phospholipase A2 and arachidonic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2899%2900111-6

7 January 2021

10.1016/S0197-4580(99)00111-6

Identifiers

DOI

1 reference

25 May 2018

PubMed ID

10867203

1 reference

25 May 2018